RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 209,801 Value ($000) $858 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 215,240 Value ($000) $1,050 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 204,080 Value ($000) $1,033 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 148,007 Value ($000) $783 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 149,808 Value ($000) $1,013 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 136,541 Value ($000) $900 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 120,136 Value ($000) $901 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 72,161 Value ($000) $719 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 72,161 Value ($000) $712 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 72,161 Value ($000) $552 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 72,161 Value ($000) $539 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 72,161 Value ($000) $481 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 72,161 Value ($000) $556 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 72,161 Value ($000) $768 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 72,161 Value ($000) $587 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 64,035 Value ($000) $458 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 41,202 Value ($000) $706 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 10,751 Value ($000) $247 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 8,708 Value ($000) $318 Avg Close $29.60 Range $19.68 - $38.39